Interleukin 23
Interleukin 23[edit | edit source]
Interleukin 23 (IL-23) is a cytokine that plays a crucial role in the immune system. It is involved in the inflammatory response and is important in the pathogenesis of several autoimmune diseases. IL-23 is a member of the IL-12 cytokine family and shares a common subunit with IL-12.
Structure[edit | edit source]
IL-23 is a heterodimeric cytokine composed of two subunits: the p19 subunit, which is unique to IL-23, and the p40 subunit, which is shared with IL-12. The p40 subunit is encoded by the IL12B gene. The structure of IL-23 allows it to bind to its specific receptor, the IL-23 receptor, which is expressed on the surface of certain immune cells.
Function[edit | edit source]
IL-23 is primarily produced by dendritic cells and macrophages. It plays a key role in the differentiation and maintenance of T helper 17 cells (Th17 cells), which are a subset of T cells involved in the immune response against extracellular pathogens and in the development of autoimmune diseases. IL-23 promotes the production of pro-inflammatory cytokines such as IL-17 and IL-22, which contribute to inflammation and tissue damage in autoimmune conditions.
Role in Disease[edit | edit source]
IL-23 has been implicated in the pathogenesis of several autoimmune diseases, including psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. In these conditions, IL-23 drives the inflammatory response by promoting the expansion and activation of Th17 cells, leading to chronic inflammation and tissue damage.
Therapeutic Target[edit | edit source]
Due to its role in autoimmune diseases, IL-23 is a target for therapeutic intervention. Several biologic drugs have been developed to inhibit IL-23 signaling, including monoclonal antibodies that specifically target the p19 subunit of IL-23. These therapies have shown efficacy in treating conditions such as psoriasis and Crohn's disease by reducing inflammation and improving clinical symptoms.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
